Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Temporary assist device for postcardiotomy cardiac failure.

Antonis A Pitsis1, Petros Dardas, Nikolaos Mezilis

  • 1Thessaloniki Heart Institute, St. Luke's Hospital, Thessaloniki, Greece.

The Annals of Thoracic Surgery
|April 6, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trajectories and outcomes in patients with cardiogenic shock receiving heart replacement therapies.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
Same author

Generalizability of Landmark Temporary MCS Device Trials: Insights From the CSWG Registry.

JACC. Advances·2026
Same author

Cardiogenic Shock Survivorship: A Multidisciplinary Approach Across the Continuum of Care.

Journal of the American College of Cardiology·2026
Same author

Machine Learning-Based Phenotypes Combined with Comorbidity Burden in Cardiogenic Shock.

European journal of heart failure·2026
Same author

Pancreatic Involvement During Acute Heart Failure: Insights from the AVANTI trial.

European journal of heart failure·2026
Same author

Factors Associated With Survival-to-Discharge in Patients With High-Risk Pulmonary Embolism Requiring Venoarterial Extracorporeal Membrane Oxygenation.

Structural heart : the journal of the Heart Team·2026

Post-cardiac surgery left ventricular failure (LVF) can be challenging. The TandemHeart percutaneous ventricular assist device (pVAD) offers a safe and effective alternative when other treatments fail.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Mechanical Circulatory Support

Background:

  • Postcardiotomy left ventricular failure (LVF) is a serious complication following cardiac surgery.
  • Intraaortic balloon pump (IABP) counterpulsation is the standard treatment for postcardiotomy LVF.
  • Management of refractory LVF remains a clinical challenge.

Observation:

  • Two cases of postcardiotomy LVF unresponsive to inotropic support and IABP were identified.
  • The TandemHeart percutaneous ventricular assist device (pVAD) was utilized in both cases.
  • Successful outcomes were achieved with pVAD support.

Findings:

  • The TandemHeart pVAD provided effective circulatory support in severe postcardiotomy LVF.
  • Patients treated with pVAD showed positive responses, indicating device efficacy.

Related Experiment Videos

  • The pVAD served as a crucial bridge to recovery.

    • Implications:

    • The TandemHeart pVAD represents a viable and safe treatment option for refractory postcardiotomy LVF.
    • This approach may improve outcomes for patients with severe cardiac failure post-surgery.
    • Further research into pVADs for cardiac failure is warranted.